Indo Borax & Chemicals Q3 FY26 Standalone Profit at ₹911 Crore, Up 2.15%
Indo Borax & Chemicals reported Q3 FY26 standalone net profit of ₹911.11 lakh, a 2.15% increase from ₹891.93 lakh in Q3 FY25. Total income rose to ₹4,513.58 lakh from ₹4,154.79 lakh. Consolidated profit for the quarter was ₹927.19 lakh. The results were approved on January 16, 2026.
The results show a modest increase in profit, which is positive but not a dramatic surge, suggesting a moderate impact on investor sentiment.
The company reported a year-on-year increase in net profit for the quarter, indicating positive financial performance.
Indo Borax & Chemicals Limited announced its standalone and consolidated un-audited financial results for the quarter and nine months ended December 31, 2025. The company reported a standalone net profit of ₹911.11 lakh for the quarter ended December 31, 2025, an increase of 2.15% from ₹891.93 lakh in the same quarter of the previous year. Total income from operations (net) for the standalone entity stood at ₹4,513.58 lakh for the quarter, up from ₹4,154.79 lakh in the corresponding quarter of the prior year.
For the nine-month period ended December 31, 2025, the standalone net profit was ₹3,523.70 lakh, compared to ₹4,188.20 lakh in the same period last year. The consolidated net profit for the quarter ended December 31, 2025, was ₹927.19 lakh, a slight increase from ₹907.07 lakh in the prior year's quarter. Consolidated total income from operations (net) was ₹4,535.12 lakh, up from ₹4,175.17 lakh year-on-year.
The Board of Directors reviewed and took on record these results at their meeting held on January 16, 2026. The detailed financial results are available on the company's website and the websites of BSE Limited and the National Stock Exchange of India Ltd.
What to do with a filing like this
Indo Borax & Chemicals Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Indo Borax & Chemicals Limited. Read the original for the full detail.